Sugammadex in different weights for motor block antagonism of bariatric surgery - clinical trial
Phase 4
- Conditions
- bariatric surgery , obesity, anesthesia , anesthetic adjuvantsD27.505.954.427.010E03.155E02.065.062
- Registration Number
- RBR-7ms62x
- Lead Sponsor
- niversidade Federal de Pernambuco
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Both genders, age between 18 and 65. BMI greater than or equal to 40 kg m -2, only included after signing the written informed consent
Exclusion Criteria
known neuromuscular diseases (eg Miastenis Gravis ) Use of drugs that interfere with the transmission neuromuscularAlergia to some of the drugs used in the study renal failure
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method